Boersma 2001.
Study characteristics | ||
General information | Objective
Journal
Country
Study design
|
|
Participants | Number of included patients
Surgical specialty
Age
Male sex
High‐risk surgery
Insulin‐dependent diabetes mellitus
History of ischaemic heart disease
History of congestive heart failure
History of cerebrovascular events
Elevated creatinine
0 RCRI factors
1 RCRI factor
2 or more RCRI factors
|
|
Predictors | Predictor 1: Dobutamine stress echocardiography (DES) + betablocker use
|
|
Outcome | Outcome category
Full outcome definition
Prediction horizon
|
|
Analysis | Number of outcomes
Handling missing data
Discrimination reported?
Calibration reported?
Reclassification reported?
|
|
PROBAST: Applicability | Domain 1: Participant selection
Justification: population very different from the development study; only high‐risk patients included Domain 2: Predictors
Justification: Domain 3: Outcome
Justification: outcome is cardiovascular death with myocardial infarction in this study and MACE in the development study Overall judgement
Justification: only high‐risk patients were included. Predictors were clearly defined. However, the outcome used was different compared to the development study. |
|
Notes | — | |
Item | Authors' judgement | Support for judgement |
Domain 1: Participant selection | No | Only patients with at least one cardiac risk factor had a DSE meaning that only high‐risk patients were assessed. |
Domain 2: Predictors | Yes | Clear (RCRI) predictor definitions were described. |
Domain 3: Outcome | Yes | Clearly defined outcome definitions and appropriate adjudication of outcomes. |
Domain 4: Analysis | No | Low number of outcomes and no information on handling missing data. |
Overall judgement | No | Only high‐risk patients were included. Predictors and outcomes were clearly defined. However, the number of outcomes was low and there was no information on handling missing data. |